4.8 Article

Hepatitis C Virus-Induced Reduction in miR-181a Impairs CD4+ T-Cell Responses Through Overexpression of DUSP6

期刊

HEPATOLOGY
卷 61, 期 4, 页码 1163-1173

出版社

WILEY-BLACKWELL
DOI: 10.1002/hep.27634

关键词

-

资金

  1. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01DK093526]
  2. National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01AI114748, R15AI072750]
  3. China Scholarship Council [CSC 201306590012]
  4. Guangzhou Municipal Health Bureau, China
  5. Guanghua Foundation of Xian Jiaotong University, China
  6. Beijing 302 Hospital, Beijing, China

向作者/读者索取更多资源

T cells play a crucial role in viral clearance or persistence; however, the precise mechanisms that control their responses during viral infection remain incompletely understood. MicroRNA (miR) has been implicated as a key regulator controlling diverse biological processes through posttranscriptional repression. Here, we demonstrate that hepatitis C virus (HCV)-mediated decline of miR-181a expression impairs CD4(+) T-cell responses through overexpression of dual specific phosphatase 6 (DUSP6). Specifically, a significant decline of miR-181a expression along with overexpression of DUSP6 was observed in CD4(+) T cells from chronically HCV-infected individuals compared to healthy subjects, and the levels of miR-181a loss were found to be negatively associated with the levels of DUSP6 overexpression in these cells. Importantly, reconstitution of miR-181a or blockade of DUSP6 expression in CD4(+) T cells led to improved T-cell responses including enhanced CD25 and CD69 expression, increased interleukin-2 expression, and improved proliferation of CD4(+) T cells derived from chronically HCV-infected individuals. Conclusion: Since a decline of miR-181a concomitant with DUSP6 overexpression is the signature marker for age-associated T-cell senescence, these findings provide novel mechanistic insights into HCV-mediated premature T-cell aging through miR-181a-regulated DUSP6 signaling and reveal new targets for therapeutic rejuvenation of impaired T-cell responses during chronic viral infection. (Hepatology 2015;61:1163-1173)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据